Research led by the University of Exeter and Kent and Medway NHS and Social Care Partnership Trust, published in Age and Ageing, assessed a new tool designed to calculate which medicines are more ...

The use of strong anticholinergic drugs, but not the weak ones, was associated with an increased risk for dementia. This association was most pronounced in men, younger patients, and those with ...

Research led by the University of Exeter and Kent and Medway NHS and Social Care Partnership Trust, published in Age and Ageing, assessed a new tool designed to calculate which medicines are more ...

Dear Dr. Roach: I suffer from frequent allergic sneezing and coughing. Every day I seem to sneeze and sniffle. A daily Zyrtec controls the symptoms, but I am reluctant to take it daily as I understand ...

Groundbreaking research reveals that long-term use of common drugs for depression, bladder control, and Parkinson’s could be ...

A comprehensive study following more than 4,000 older adults for more than eight years revealed that anticholinergic medications are associated with faster physical decline than what’s typically seen ...

Higher anticholinergic exposure was associated with accelerated decline in gait speed (-0.0132 m/s per year) and grip strength in older adults, with effects most pronounced within 4-6 years of ...

A class of drug commonly used to treat everything from chronic obstructive pulmonary disease (COPD) to depression has now been linked to accelerating the loss of mobility in older age. This adds a new ...

Kaiser Permanente Washington scientists report that higher cumulative anticholinergic exposure predicted a faster decline in gait speed and grip strength among older adults. Older adults frequently ...